Actively Recruiting
Evaluating Accuracy of Home Lactate and Glucose Meters in Patients With Glycogen Storage Disease Type Ia
Led by Connecticut Children's Medical Center · Updated on 2026-03-06
10
Participants Needed
1
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
This observational study is focused on patients with glycogen storage disease type 1a. Researchers aim to determine how accurate home lactate meters, which use capillary and serum samples, are compared to laboratory serum lactate measurements. The study also evaluates the accuracy of the Accu Chek Guide glucometer, which uses capillary samples, in the same patient population. Participants will use home devices to measure blood lactate and glucose levels via finger-stick samples. These home measurements will be compared to lab results to assess accuracy within 20% of the lab values 95% of the time. The study involves monitoring these readings every 1 to 3 hours for up to 33 hours. Participants will be observed during their visits or admissions to Connecticut Childrens Medical Center. Data collection includes frequent home meter readings and laboratory tests to compare results. The primary outcome is the accuracy of the home lactate meters, while the glucometer accuracy is a secondary outcome. The study runs from April 2025 until December 2027, and participants may be monitored for up to 33 hours during data collection periods.
CONDITIONS
Brief Title
Accuracy of Lactate Meter in GSDIa
Research Team
M
Malaya Mount, MS, RD
R
Rebecca Riba-Wolman, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here